Eli Lilly & Co. will pay $22.5 million to settle a federal lawsuit filed by the West Virginia Attorney General’s Office over the popular anti-psychotic drug Zyprexa.
In the settlement, the Indianapolis-based company agreed to pay $15.75 million to West Virginia and $6.75 million to lawyers who represented the state.
The settlement says $14.75 million will be used to fund behavioral health care, and the remaining $1 million will go to consumer protection.
Lilly didn’t acknowledge wrongdoing. West Virginia had claimed the company improperly marketed the drug.
Lilly settled a lawsuit over Zyprexa involving 30 states in January for $1.42 billion. The company still faces lawsuits in 11 other states.
U.S. District Judge Jack Weinstein in Brooklyn, N.Y., approved West Virginia’s settlement in late July.
Was this article valuable?
Here are more articles you may enjoy.
EVs Head for Junkyard as Mechanic Shortage Inflates Repair Costs 
J&J, Kenvue Told to Pay $45 Million to Baby Powder User’s Family 
Poll: Consumers OK with AI in P/C Insurance, but Not So Much for Claims and Underwriting 
SC High Court Strikes ‘Troubling’ Denial of Comp Claim, Says Can’t Be Based on Stats 
Want to stay up to date?
Get the latest insurance news
sent straight to your inbox.